Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays

Overview of attention for article published in Seminars in Surgical Oncology, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source

twitter: 5 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Genexpressionsbaserade tester för vägledning av återfallsförebyggande behandling vid bröstcancer

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 27 Jun 2018

SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.